Kazakhstan Pharmaceuticals and Healthcare Report

 Published On: Mar, 2016 |    No of Pages: 76 |  Published By: BMI Pharmaceuticals and Healthcare | Format: PDF
Request Free Sample

BMI View: The establishment of a national health insurance fund will markedly boost sales of pharmaceuticals in Kazakhstan. A reliance on foreign pharmaceutical imports, the population's increasing access to healthcare and the government's long-term vision to become a top developed country will see attractive revenue earning opportunities presented to multinational drugmakers. However, lower than expected real GDP growth for 2016 to 2020 due to low oil prices and tenge devaluation affecting purchasing power will dampen market growth in the short term.

Headline Expenditure Projections
■ Pharmaceuticals: KZT350bn (USD1.57bn) in 2015 to KZT382bn (USD1.15bn) in 2016; +9.3% in local currency terms and -26.8% in US dollar terms. Forecast revised downwards from last quarter.
■ Healthcare: KZT2.05trn (USD9.19bn) in 2015 to KZT2.34trn (USD7.04bn) in 2016; +14.5% in local currency terms and -23.3% in US dollar terms. Forecast revised downwards from last quarter.

BMI Industry View ....... 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Kazakhstan 2014-2020)          . . 7
SWOT .. 9
Industry Forecast ...... 11
Pharmaceutical Market Forecast ........ 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kazakhstan 2012-2020)         . . . . . . 13
Healthcare Market Forecast . 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020)        . . . 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020)      . . . 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020)       . 18
Prescription Drug Market .... 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020)       . . . . 20
Patented Drug Market Forecast ......... 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020)        . 22
Generic Drug Market Forecast .......... 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020)        . 25
OTC Medicine Market Forecast ......... 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020)    . . . . . . 28
Pharmaceutical Trade Forecast ......... 29
Table: Pharmaceutical Trade Data And Forecasts (Kazakhstan 2014-2020)           . . . 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Kazakhstan 2014-2020)         . 31
Industry Risk/Reward Index .. 32
Central And Eastern Europe Risk/Reward Index . 32
Kazakhstan Risk/Reward Index ........... 38
Rewards  38
Risks ..... 39
Regulatory Review .... 40
Intellectual Property Issues . 41
Pricing And Reimbursement Regime .. 43
Market Overview ....... 46
Healthcare Sector  47
Clinical Trials ..... 50
Epidemiology ...... 50
Competitive Landscape ......... 53
Research-Based Industry .... 53
Table: Multinational Market Activity                 . . . 57
Pharmaceutical Distribution ............ 58
Pharmaceutical Retail Sector ........... 60
Company Profile ........ 61
Chimpharm .......... 61
Romat .... 63
Demographic Forecast .......... 65
Demographic Outlook ......... 65
Table: Population Headline Indicators (Kazakhstan 1990-2025)             . . 66
Table: Key Population Ratios (Kazakhstan 1990-2025)              . . . . 66
Table: Urban/Rural Population & Life Expectancy (Kazakhstan 1990-2025)           . . . 67
Table: Population By Age Group (Kazakhstan 1990-2025)              . 67
Table: Population By Age Group % (Kazakhstan 1990-2025)             . . . . . 68
Glossary ........ 70
Methodology . 72
Pharmaceutical Expenditure Forecast Model ... 72
Healthcare Expenditure Forecast Model .......... 72
Notes On Methodology ....... 73
Risk/Reward Index Methodology ....... 74
Index Overview .... 75
Table: Pharmaceutical Risk/Reward Index Indicators              . . . . . . 75
Indicator Weightings ......... 76
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.